TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7395839

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 25
Study: 31385920

Group type: EXPERIMENTAL
Intervention: Recommendations by expert faculty
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Recommendations for treatment
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Knowledge translation process
Number of subjects: 197
Study: 28789490

Group type: EXPERIMENTAL
Intervention: Testa triticum tricum purif (3.5 g bid)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Polyethylene glycol 4000 (PEG4000, 10g bid)
Number of subjects: 122
Study: 25762057

Group type: EXPERIMENTAL
Intervention: probe‐based CLE (pCLE)
Number of subjects: 513

Group type: COMPARATOR
Intervention: endoscope‐based CLE (eCLE)
Number of subjects: 513
Study: 23660085

Group type: EXPERIMENTAL
Intervention: Ramosetron combined with midazolam at induction of anaesthesia (group RM1)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Ramosetron combined with midazolam at the end of surgery (group RM2)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Ramosetron alone (group R)
Number of subjects: 126
Study: 20831662

Group type: EXPERIMENTAL
Intervention: Fecal occult blood test with stop screen design
Number of subjects: 86150
Study: 19712191

Group type: EXPERIMENTAL
Intervention: Leaflet containing child‐friendly dental information (experimental group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Leaflet with child‐friendly information on the benefits of healthy eating (control group)
Number of subjects: 50
Study: 18022061

Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention
Number of subjects: 660

Group type: COMPARATOR
Intervention: Comparison community
Number of subjects: 660
Study: 15163110

Group type: EXPERIMENTAL
Intervention: Ultrasonographically guided peritendinous injection of steroid
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 48
Study: 11352337

Group type: EXPERIMENTAL
Intervention: Imipramine 150 mg/day
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sertraline 50 mg/day
Number of subjects: 55
Study: 11024375

Group type: EXPERIMENTAL
Intervention: ETHI (video-assisted dissector)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: AUTS (light coupled retractor)
Number of subjects: 66

Group type: COMPARATOR
Intervention: CONV (traditional open technique)
Number of subjects: 66
Study: 9193370

Group type: EXPERIMENTAL
Intervention: Ondansetron plus metopimazine
Number of subjects: 111

Group type: COMPARATOR
Intervention: Ondansetron alone
Number of subjects: 111
Study: 1524965

Group type: EXPERIMENTAL
Intervention: Inhaled frusemide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study: 3889257

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin intramuscularly plus rifampin orally (10 mg/kg twice a day for eight doses)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Benzathine penicillin intramuscularly
Number of subjects: 38

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin intramuscularly plus rifampin
Number of subjects: 38
Study: 29146743

Group type: EXPERIMENTAL
Intervention: Adalimumab + Methotrexate (MTX)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 926
Study: 26776435

Group type: EXPERIMENTAL
Intervention: Fibrinogen 5.5mg and thrombin 2IU applied as a tissue sealant and gastrointestinal reinforcement sutures (Group B)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 73
Study: 25375075

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation (50 mg twice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22498211

Group type: EXPERIMENTAL
Intervention: Real-time elastography guided biopsy
Number of subjects: 353

Group type: COMPARATOR
Intervention: Gray scale ultrasound guided biopsy
Number of subjects: 353
Study: 20102894

Group type: EXPERIMENTAL
Intervention: CRP levels > or =2 mg/L
Number of subjects: 30329

Group type: COMPARATOR
Intervention: CRP levels <2 mg/L
Number of subjects: 30329
Study: 18594354

Group type: EXPERIMENTAL
Intervention: 2-octyl-cyanoacrylate skin adhesive (Dermabond)
Number of subjects: 50
Study: 15982146

Group type: EXPERIMENTAL
Intervention: 6-session parent-education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 11858610

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% eye drops once a day in both eyes for 4 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Unpreserved substitute tears eye drops (Aquasalina) with the same posology and concentration of benzalkonium chloride (0.02%)
Number of subjects: 14
Study: 10408559

Group type: EXPERIMENTAL
Intervention: Diclofenac/misoprostol (D/M)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 7674143

Group type: EXPERIMENTAL
Intervention: Low-dose SH/TA-508 (1.5-1.6g galactose)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: High-dose SH/TA-508 (3.0-3.2g galactose)
Number of subjects: 196

Group type: COMPARATOR
Intervention: SH/TA-508 at 200 mg/ml concentration
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: SH/TA-508 at 300 mg/ml concentration
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: SH/TA-508 at 400 mg/ml concentration
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Color Doppler echocardiography with SH/TA-508
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Higher doses and concentrations of SH/TA-508
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Optimum concentration for two-dimensional echocardiography
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Optimum concentration for color Doppler echocardiography
Number of subjects: 196
Study: 2402834

Group type: EXPERIMENTAL
Intervention: Intensive social assistance for five months in cooperation with the general practitioner
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intensive social assistance)
Number of subjects: 100
Study: 30737585

Group type: EXPERIMENTAL
Intervention: day‐3 hatching‐based TE biopsy
Number of subjects: 221

Group type: COMPARATOR
Intervention: new biopsy group (TE biopsy without hatching)
Number of subjects: 221
Study: 27636913

Group type: EXPERIMENTAL
Intervention: 20% sucrose solution
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: milk
Number of subjects: 33

Group type: COMPARATOR
Intervention: water
Number of subjects: 33
Study: 26886521

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 790

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 790
Study: 24650818

Group type: EXPERIMENTAL
Intervention: Alcohol use (every drink consumed above one's mean)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Previous sexual victimization (PSV)
Number of subjects: 120
Study: 22764609

Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20923474

Group type: EXPERIMENTAL
Intervention: Local dry heat + Electrical Stimulation (ES)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Local dry heat only
Number of subjects: 20
Study: 18703803

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant therapy (OAT) related ICH
Number of subjects: 303

Group type: COMPARATOR
Intervention: Spontaneous ICH (SICH)
Number of subjects: 303
Study: 15741530

Group type: EXPERIMENTAL
Intervention: Folate (5 mg) and mecobalamin (1500 microg)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Folate and mecobalamin
Number of subjects: 628
Study: 12675867

Group type: EXPERIMENTAL
Intervention: Vitamin E-bonded cellulose membrane dialyzer (EE)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cellulose membrane (SU)
Number of subjects: 34
Study: 10819408

Group type: EXPERIMENTAL
Intervention: Chronic oral administration of beta-blocker
Number of subjects: 44

Group type: COMPARATOR
Intervention: Baseline recordings using FFT spectral method
Number of subjects: 44

Group type: COMPARATOR
Intervention: Both spectral methods
Number of subjects: 44

Group type: COMPARATOR
Intervention: Low-frequency component of heart rate variability
Number of subjects: 44
Study: 8670033

Group type: EXPERIMENTAL
Intervention: Laser conditioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acid etching
Number of subjects: 0
Study: 1353506

Group type: EXPERIMENTAL
Intervention: Propranolol (0.20 mg/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Metoprolol (0.25 mg/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pindolol (0.04 mg/kg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 17
Study: 6329254

Group type: EXPERIMENTAL
Intervention: Oral evening primrose oil
Number of subjects: 41

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 41
Study: 31122997

Group type: EXPERIMENTAL
Intervention: Tailored, individualised information via the Internet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Untailored information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 29932807

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control (no practice)
Number of subjects: 246
Study: 26986848

Group type: EXPERIMENTAL
Intervention: Free screening offer
Number of subjects: 3124

Group type: COMPARATOR
Intervention: Standard invitation with a fee of 100 SEK (≈11 €)
Number of subjects: 3124
Study: 24486563

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (16 IU)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22340552

Group type: EXPERIMENTAL
Intervention: Computer navigation‐assisted total knee replacement
Number of subjects: 82
Study: 19590506

Group type: EXPERIMENTAL
Intervention: Telmisartan (40-80 mg per day) plus Hydrochlorothiazide (12.5 mg per day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Amlodipine (5-7.5 mg per day)
Number of subjects: 75
Study: 17368522

Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) chemotherapy with cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous (IV) chemotherapy
Number of subjects: 0
Study: 15777483

Group type: EXPERIMENTAL
Intervention: Food supplementation provided by the World Food Programme
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Additional oil provided to some families
Number of subjects: 360
Study: 11973194

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.08 microg x kg(‐1) x min(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 20
Study: 9838801

Group type: EXPERIMENTAL
Intervention: Reduced sodium intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary interventions
Number of subjects: 0
Study: 7657286

Group type: EXPERIMENTAL
Intervention: Nadolol (NAD) plus isosorbide-5-mononitrate (I5M)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Nadolol (NAD) alone
Number of subjects: 81
Study: 2558700

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion (0.4 nmol kg‐1 min‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: CWT (mental stress)
Number of subjects: 0
Study: 1104668

Group type: EXPERIMENTAL
Intervention: Halcinonide cream applied three times daily for two to three weeks
Number of subjects: 392

Group type: COMPARATOR
Intervention: Fluocinonide cream applied three times daily for two to three weeks
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Both creams
Number of subjects: 392
Study: 30985671

Group type: EXPERIMENTAL
Intervention: Real laser acupuncture treatment (LAT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham laser acupuncture treatment
Number of subjects: 32
Study: 28622950

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300U/mL (Gla-300)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Insulin glargine 100U/mL (Gla-100)
Number of subjects: 878
Study: 25760346

Group type: EXPERIMENTAL
Intervention: PCT-guided antibiotic treatment for either 3 or 10 days
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard antibiotic treatment for 10 days
Number of subjects: 184
Study: 23247001

Group type: EXPERIMENTAL
Intervention: Original PQAS
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Revised PQAS
Number of subjects: 41
Study: 21595618

Group type: EXPERIMENTAL
Intervention: Pure tone masking‐tinnitus retraining therapy (TRT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Betahistine dihydrochloride
Number of subjects: 91

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 91
Study: 18534547

Group type: EXPERIMENTAL
Intervention: Retransfusion drains removed at 6 hours postoperatively
Number of subjects: 80

Group type: COMPARATOR
Intervention: Retransfusion drains removed at 24 hours postoperatively
Number of subjects: 80
Study: 15707477

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 2383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2383
Study: 12622930

Group type: EXPERIMENTAL
Intervention: lamivudine 100 mg daily (n = 322)
Number of subjects: 429

Group type: COMPARATOR
Intervention: placebo (n = 107)
Number of subjects: 429
Study: 10604415

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 7486295

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.08 mg.kg-1)
Number of subjects: 152

Group type: COMPARATOR
Intervention: No Vecuronium (Vecu0 group)
Number of subjects: 152
Study: 1936510

Group type: EXPERIMENTAL
Intervention: 10 mg ketorolac tromethamine given orally four times daily for 3 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: 500 mg diflunisal given orally twice daily plus placebo twice daily for 3 days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diflunisal
Number of subjects: 100
Study: 7117684

Group type: EXPERIMENTAL
Intervention: 330 mg ultramicrosize griseofulvin tablet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Two 165 mg ultramicrosize griseofulvin tablets
Number of subjects: 16

Group type: COMPARATOR
Intervention: 500 mg microsize griseofulvin formulation
Number of subjects: 16
Study: 30690902

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVT‐AFL)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 115
Study: 28559749

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program plus SNAG (3 times per week for 1 month)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional physical therapy program without SNAG (3 times per week for 1 month)
Number of subjects: 42
Study: 26270684

Group type: EXPERIMENTAL
Intervention: Treatment for asymptomatic bacteriuria (AB) in group B
Number of subjects: 550

Group type: COMPARATOR
Intervention: No treatment for asymptomatic bacteriuria in group A
Number of subjects: 550
Study: 25022130

Group type: EXPERIMENTAL
Intervention: Navel-warming therapy combined with western medication
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication alone
Number of subjects: 120
Study: 22526517

Group type: EXPERIMENTAL
Intervention: FLU 1200 mg/day + 5-FC 100 mg/kg/day for 14 days + AmB 1 mg/kg/day for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: FLU 1200 mg/day + AmB 1 mg/kg/day for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: FLU 1200 mg/day + 5-FC 100 mg/kg/day for 14 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: FLU alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Addition of 5-FC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Addition of AmB
Number of subjects: 40
Study: 19943469

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 126
Study: 17329297

Group type: EXPERIMENTAL
Intervention: Ispronicline 50 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Ispronicline 100 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Ispronicline 150 mg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 15385365

Group type: EXPERIMENTAL
Intervention: Bispectral Index (BIS)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rapidly extracted auditory evoked potentials index (AAI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Comparison of BIS and AAI
Number of subjects: 21
Study: 11435270

Group type: EXPERIMENTAL
Intervention: Long-term antipsychotic treatment
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (specifically olanzapine)
Number of subjects: 59
Study: 10235018

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) for symptomatic plaques
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) for asymptomatic plaques
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Asymptomatic contralateral carotid artery disease followed with CEA
Number of subjects: 57
Study: 7543344

Group type: EXPERIMENTAL
Intervention: Inhaled acetaldehyde
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhaled histamine
Number of subjects: 9
Study: 2712260

Group type: EXPERIMENTAL
Intervention: Nellcor N-200
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nellcor N-100
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Various fractions of oxygen
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lateral position
Number of subjects: 46

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 46
Study: 238792

Group type: EXPERIMENTAL
Intervention: 15 mg. monohydrochloride salt of flurazepam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30 mg. dihydrochloride salt of flurazepam
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31237451

Group type: EXPERIMENTAL
Intervention: 40-hour fast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycine-conjugated deoxycholic acid (gDCA) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overnight fast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4-hour mixed meal test with gDCA
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4-hour mixed meal test without gDCA
Number of subjects: 0
Study: 28379964

Group type: EXPERIMENTAL
Intervention: 2000mg ω-3 supplements
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control capsule
Number of subjects: 64
Study: 25986476

Group type: EXPERIMENTAL
Intervention: ICU care for 24 hours
Number of subjects: 104
Study: 23899642

Group type: EXPERIMENTAL
Intervention: 20 mg THC
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21737071

Group type: EXPERIMENTAL
Intervention: Thawed embryos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresh embryos
Number of subjects: 0
Study: 20178280

Group type: EXPERIMENTAL
Intervention: Auditory feedback
Number of subjects: 15

Group type: COMPARATOR
Intervention: Visual feedback
Number of subjects: 15

Group type: COMPARATOR
Intervention: Auditory + Visual feedback
Number of subjects: 15
Study: 16420204

Group type: EXPERIMENTAL
Intervention: Overweight subjects
Number of subjects: 2684

Group type: EXPERIMENTAL
Intervention: Class I obesity (BMI 30.0-34.9 kg/m2)
Number of subjects: 2684

Group type: EXPERIMENTAL
Intervention: Class II obesity (BMI >35.0 kg/m2)
Number of subjects: 2684
Study: 14738232

Group type: EXPERIMENTAL
Intervention: Maintenance inspiratory muscle training (IMT) for one year
Number of subjects: 38

Group type: COMPARATOR
Intervention: Very low load training (control group)
Number of subjects: 38
Study: 11641004

Group type: EXPERIMENTAL
Intervention: Willingness to pay (WTP) for mammography among different ethnic groups
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: Familial link to breast cancer
Number of subjects: 1465
Study: 9028539

Group type: EXPERIMENTAL
Intervention: Maternal history of hip fracture
Number of subjects: 12816

Group type: EXPERIMENTAL
Intervention: Paternal history of hip fracture
Number of subjects: 12816

Group type: COMPARATOR
Intervention: Control group (no maternal hip fracture)
Number of subjects: 12816
Study: 8505112

Group type: EXPERIMENTAL
Intervention: Low sodium diet (70 mmol sodium intake per day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Potassium chloride supplementation (1 mmol/kg potassium chloride per day)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (normal diet plus placebo capsule)
Number of subjects: 210
Study: 3277760

Group type: EXPERIMENTAL
Intervention: Povidone‐iodine
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Repeated triple dye application
Number of subjects: 271

Group type: COMPARATOR
Intervention: All methods
Number of subjects: 271
Study: 31895461

Group type: EXPERIMENTAL
Intervention: Protected nonclinical time (2 hours per week)
Number of subjects: 19
Study: 31431445

Group type: EXPERIMENTAL
Intervention: Strengthening exercises in combination with lumbar force accuracy training exercises
Number of subjects: 94

Group type: COMPARATOR
Intervention: Strengthening exercises alone
Number of subjects: 94
Study: 28316019

Group type: EXPERIMENTAL
Intervention: Rebamipide (100 mg single oral dose)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined MDR1 3435C>T and body mass index as covariates for ka 1
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Body surface area as a covariate
Number of subjects: 26
Study: 25441178

Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Aerobic plus strength training with linear periodization (LP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Aerobic plus strength training with daily undulating periodization (DUP)
Number of subjects: 45
Study: 24043256

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Metformin + Rosiglitazone (ROSI)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Metformin + Lovaza (LOV)
Number of subjects: 78